A Multiple Center, Open-label, Single Dose, Parallel-group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 18 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Jan 2012 New trial record